Kanya Rajangam
Overview
Kanya Rajangam received an average of $776K in total compensation, including $428K in salary, at Senti Biosciences from 2022 to 2024. Kanya Rajangam also received an average of $2M at Nkarta between 2020 and 2021.
- 2024
- 2023
- 2022
- 2021
- 2020
Senti BiosciencesPresident, Head of Research and Development and Chief Medical Officer
Senti BiosciencesPresident, Head of Research and Development and Chief Medical Officer
Senti BiosciencesHead of Research and Development and Chief Medical Officer
NkartaChief Medical Officer
NkartaChief Medical Officer
Source: SEC filings on January 27, 2025, April 28, 2023, and April 21, 2022.
Related executives
We found 11 more executives who work or worked at Senti Biosciences and Nkarta.
Timothy Lu
Senti Biosciences
Chief Executive Officer
Yvonne Li
Senti Biosciences
Chief Financial Officer
Paul Hastings
Nkarta
Chief Executive Officer
David Shook
Nkarta
Chief Medical Officer
Alyssa Levin
Nkarta
Chief Financial and Business Officer
Paul Hastings
Nkarta
Chief Executive Officer
Alicia Hager
Nkarta
Chief Legal Officer
Nadir Mahmood
Nkarta